SunOpta STKL Q4 2025 Beat Revenue NA EPS Exceeds by Significant US Treasury Yields Dip but LongTerm Outlook Points Higher ING Says Conduent CNDT Delivers Q1 2026 Beat EPS 005 vs 019 Expected Bond Market Pressure Clouds Kevin Warshs Plans to Shrink Fed Balance Sheet Indian Equity Indices Surge Over 1 on Strong Global Cues Indian Markets Open Flat After Monday Rally Crude Oil Surges on USIran Tensions US Consumer Sentiment Remains Depressed Amid Inflation Geopolitical Tensions and Trade Policy Uncertainty Asian Stocks Poised for Decline Amid Conflicting USIran Geopolitical Signals Guzman y Gomez Exits US Market Amid Stiff Competition and Operational Challenges Plus500 Revenue Rises 11 in Latest Quarter Company Expects to Meet FullYear Targets COSO Q1 2026 Earnings EPS Misses Estimates amid Tightening Margins 374Water Inc SCWO Q1 2026 Earnings Narrowing Losses and Commercial Progress Highlight a Quarter of Transition CNMD Q1 2026 Earnings EPS Surprise Fails to Lift Stock as Revenue Picture Stays Cloudy Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear CETY Q4 2024 Earnings Net Loss of 002 Per Share Stock Unchanged Amid Minimal Disclosure CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment Tyler Technologies TYL Faces Modest Pullback as Key Support Levels Come Into Focus SelectQuote Inc SLQT Slides 566 to 10 as Sellers Test Support Near 095 Hub Group Inc HUBG Slips 127 as Logistics Sector Faces Headwinds HLX Stock Advances Slightly as Helix Energy Solutions Holds Key Support Ocugen Inc OCGN Holds Steady at 134 Amid Consolidation Key Levels in Focus SBEV Q2 2025 Earnings Widerthanexpected loss sends shares lower PANW Q1 2026 Earnings EPS Surpasses Estimates Stock Rises ACMR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Two Harbors TWOD Q1 2026 Earnings EPS Surges Past Estimates as Interest Rate Environment Supports Mortgage REIT Performance SNES Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain AnheuserBusch InBev Shares Edge Lower as Revenue Misses Analyst Forecasts LUNR Q1 2026 Earnings Wide EPS Miss Amid Stock Surge as Investors Focus on Business Milestones Acumen Pharmaceuticals ABOS Surges 62 Above Support as Biotech Momentum Builds